Safety and Immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic stem cell transplantation (alloHCT)

Due to the morbidity and mortality of meningococcal disease, the Advisory Committee of Immunization Practices recommended in 2007 immunization of all children 11–18 years old with a protein-conjugated meningococcal vaccine. There is limited data on the immunogenicity of this vaccine following alloHC...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Mahler, Michelle B., Taur, Ying, Jean, Raymond, Kernan, Nancy A, Prockop, Susan E, Small, Trudy N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286795/
https://ncbi.nlm.nih.gov/pubmed/21820392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2011.07.027
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller